A Yuan, PC Yang, CJ Yu, YC Lee, YT Yao, CL Chen, LN Lee, SH Kuo and KT Luh
Department of Internal Medicine, National Taiwan University Hospital and Institute of Biomedical Sciences, Academia Sinica, Taipei, Republic of China.

This study investigated the clinico-pathologic correlation of tumor angiogenesis in non-small-cell lung cancers. Formalin-fixed, paraffin- embedded surgical specimens of 55 consecutive patients with primary non- small-cell lung cancers were examined. Included were 26 squamous cell carcinomas and 29 adenocarcinomas. Twenty-five patients had stage I disease, eight patients had stage II disease, and 22 patients had stage IIIA or IIIB disease. Among them, 28 had nodal metastasis and 27 did not. The microvessel was demonstrated by immunocytochemical staining for factor VIII and platelet endothelial cell adhesion molecules (PECAM- 1). The microvessels in the areas of highest neovascularization were counted under light microscopy in 200x field by two independent observers without knowledge of clinical information. At least three separate fields were counted for each specimen. The Mann-Whitney U test was used for statistical analysis. The microvessel counts in adenocarcinoma were significantly higher than in the squamous cell carcinoma (54.4 +/- 35.65 versus 26.16 +/- 20.46 in factor VIII staining and 80.52 +/- 48.42 versus 40.04 +/- 32.33 in PECAM-1 staining; p < 0.001). The microvessel counts in patients with Stages I- II disease were significantly lower than that of stages IIIA-IIIB disease (23.63 +/- 16.21 versus 65.36 +/- 31.92 in factor VIII staining and 41.85 +/- 36.76 versus 93.00 +/- 43.08 in PECAM-1; p < 0.001). Patients with nodal metastasis had higher microvessel density than those without nodal metastasis (56.67 +/- 35.55 versus 23.44 +/- 15.77 in factor VIII staining and 86.89 +/- 46.46 versus 36.30 +/- 25.83 in PECAM-1 staining; p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				R. Zhai, G. Liu, W. Zhou, L. Su, R. S. Heist, T. J. Lynch, J. C. Wain, K. Asomaning, X. Lin, and D. C. Christiani Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non-Small Cell Lung Cancer Clin. Cancer Res., January 15, 2008; 14(2): 612 - 617. [Abstract] [Full Text] [PDF]

				J. H. Park, K. J. Park, Y. S. Kim, S. S. Sheen, K. S. Lee, H. N. Lee, Y. J. Oh, and S. C. Hwang Serum Angiopoietin-2 as a Clinical Marker for Lung Cancer Chest, July 1, 2007; 132(1): 200 - 206. [Abstract] [Full Text] [PDF]

				B. Hassouneh, M. Islam, T. Nagel, Q. Pan, S. D. Merajver, and T. N. Teknos Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer Mol. Cancer Ther., March 1, 2007; 6(3): 1039 - 1045. [Abstract] [Full Text] [PDF]

				K. Takenaka, E. Ogawa, H. Oyanagi, H. Wada, and F. Tanaka Carbonyl Reductase Expression and Its Clinical Significance in Non-Small-Cell Lung Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1972 - 1975. [Abstract] [Full Text] [PDF]

				C. A. Pinto, P. E. d. O. Carvalho, L. Antonangelo, A. Garippo, A. G. P. da Silva, F. Soares, R. Younes, R. Beyruti, T. Takagaki, P. Saldiva, et al. Morphometric Evaluation of Tumor Matrix Metalloproteinase 9 Predicts Survival after Surgical Resection of Adenocarcinoma of the Lung Clin. Cancer Res., August 1, 2003; 9(8): 3098 - 3104. [Abstract] [Full Text] [PDF]

				A. Yuan, C.-J. Yu, K.-T. Luh, S.-H. Kuo, Y.-C. Lee, and P.-C. Yang Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung Cancer J. Clin. Oncol., February 15, 2002; 20(4): 900 - 910. [Abstract] [Full Text] [PDF]

				P. G. Phillips, L. M. Birnby, A. Narendran, and W. L. Milonovich Nitric oxide modulates capillary formation at the endothelial cell-tumor cell interface Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L278 - L290. [Abstract] [Full Text] [PDF]

				A. Yuan, C.-J. Yu, S.-H. Kuo, W.-J. Chen, F.-Y. Lin, K.-T. Luh, P.-C. Yang, and Y.-C. Lee Vascular Endothelial Growth Factor 189 mRNA Isoform Expression Specifically Correlates With Tumor Angiogenesis, Patient Survival, and Postoperative Relapse in Non-Small-Cell Lung Cancer J. Clin. Oncol., January 15, 2001; 19(2): 432 - 441. [Abstract] [Full Text] [PDF]

				A. YUAN, P.-C. YANG, C.-J. YU, W.-J. CHEN, F.-Y. LIN, S.-H. KUO, and K.-T. LUH Interleukin-8 Messenger Ribonucleic Acid Expression Correlates with Tumor Progression, Tumor Angiogenesis, Patient Survival, and Timing of Relapse in Non-Small-Cell Lung Cancer Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1957 - 1963. [Abstract] [Full Text]

				J. A. Belperio, M. P. Keane, D. A. Arenberg, C. L. Addison, J. E. Ehlert, M. D. Burdick, and R. M. Strieter CXC chemokines in angiogenesis J. Leukoc. Biol., July 1, 2000; 68(1): 1 - 8. [Abstract] [Full Text]

				N. SHIJUBO, T. UEDE, S. KON, M. MAEDA, T. SEGAWA, A. IMADA, M. HIRASAWA, and S. ABE Vascular Endothelial Growth Factor and Osteopontin in Stage I Lung Adenocarcinoma Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1269 - 1273. [Abstract] [Full Text]